PRNP
MOLECULAR TARGETprion protein (Kanno blood group)
PRNP (prion protein (Kanno blood group)) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PRNP
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Anisomycin | 1.39 | 3 |
| 2 | cycloheximide | 1.39 | 3 |
| 3 | torin 1 | 1.39 | 3 |
| 4 | Tubercidin | 1.39 | 3 |
| 5 | urolithin b | 1.10 | 2 |
| 6 | Azacitidine | 0.69 | 1 |
| 7 | Azacitidine | 0.69 | 1 |
| 8 | Dasatinib | 0.69 | 1 |
| 9 | Hexachlorophene | 0.69 | 1 |
| 10 | Promethazine | 0.69 | 1 |
About PRNP as a Drug Target
PRNP (prion protein (Kanno blood group)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented PRNP interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PRNP inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.